Enter assignee name

Trademarks = 9

Forward Citations = 3

Loading Chart...

10 inventors (with patents filed for the assignee):

Yong Sen Zheng (3 out of 55 patents)

Jing Li (3 out of 18 patents)

Gennady Gololobov (2 out of 4 patents)

4. Jianqing Xu (2 out of 10 patents)

5. Jing Li (2 out of 89 patents)

6. Zhuozhi Wang (1 out of 12 patents)

7. Jingjing Liu (1 out of 40 patents)

8. Zhisheng Chen (1 out of 5 patents)

9. Qiong Wu (1 out of 3 patents)

10. Zhuozhi Wang (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12371493 - Monoclonal antibody against human LAG-3, method for preparing the same, and use thereof (2025-07-29),

2. 12240906 - Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (2025-03-04),

3. 12180282 - Anti-PD-L1 antibodies (2024-12-31),

4. 12054554 - Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereof (2024-08-06),

5. 11643463 - Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (2023-05-09),

Wuxi Biologics is a leading global open-access biologics technology platform that provides end-to-end solutions for biologics discovery, development, and manufacturing. Established in 2015, the company specializes in monoclonal antibodies, recombinant proteins, and other biologics. With state-of-the-art facilities and a commitment to innovation, Wuxi Biologics supports pharmaceutical and biotechnology companies in accelerating their drug development processes. The company is dedicated to quality, efficiency, and customer satisfaction, making it a trusted partner in the biopharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

5 Patents

#392 in Shanghai

#4,575 in China

Shanghai, China

Wuxi Biologics (shanghai) Co., Ltd.